The objective of the study is to develop and validate a molecular diagnostic strategy (RT-ddPCR multiplex) of COVID-19 based on a saliva sample and alternative to the RT-qPCR method, in order to : 1. to compensate for the risk of a shortage of diagnostic kits, reagents and materials necessary for molecular diagnosis; 2. to increase the molecular diagnostic capacity of COVID-19 at the Rouen University Hospital; 3. and to have a method compatible with screening extended to populations at risk.
Diagnostic Test: Saliva collection
Saliva collection will be done in addition to standard diagnosis collection (nasopharyngeal collection using swab)
Inclusion Criteria:
- Person aged over 18 years presenting to the COVID-19 consultation of the Rouen
University Hospital for screening
- Person affiliated to a social security scheme
Exclusion Criteria:
- Person objecting to participation in the research after reading information
- Person under the protection of justice,
- Person deprived of their liberty by administrative or judicial decision (guardianship,
curatorship, etc.)
- Patient under guardianship or curatorship
Rouen University Hospital
Rouen, France
Thierry FREBOURG, Pr, Principal Investigator
Rouen University Hospital